Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Patients With Chronic Migraine.

Trial Profile

Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Patients With Chronic Migraine.

Completed
Phase of Trial: Phase II

Latest Information Update: 10 Sep 2017

At a glance

  • Drugs Erenumab (Primary)
  • Indications Migraine
  • Focus Registrational; Therapeutic Use
  • Sponsors Amgen
  • Most Recent Events

    • 10 Sep 2017 Results of a subgroup analysis assessing efficacy of erenumab in patient with chronic migraine with aura and without aura, were presented at the 2017 International Headache Society.
    • 10 Sep 2017 Results of post hoc analysis assessing efficacy prior to week 4 in patient with chronic migraine treated with Erenumab, were presented at the 2017 International Headache Society.
    • 07 Sep 2017 Data published in an Novartis Media Release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top